ImmunityBio OverviewImmunityBio Net Income
Profitability analysis for IBRX.
Quarterly Net Income
-$632.78M
↓ 388.08% YoY
As of Mar 2026
Annual Net Income (TTM)
-$854.53M
↓ 108.88% YoY
Trailing 12 months ending Mar 2026
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...